Skip to content

Effects of different doses of esketamine on perioperative EEG and postoperative recovery quality in elderly patients undergoing major abdominal surgery

Effects of different doses of esketamine on perioperative EEG and postoperative recovery quality in elderly patients undergoing major abdominal surgery

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082858
Enrollment
Unknown
Registered
2024-04-09
Start date
2023-12-19
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elderly patients undergoing major abdominal surgery

Interventions

Low dose Esketamine group (E1 group):After induction of anesthesia, a load dose of 0.125 mg/kg esketamine was administered, followed by continuous infusion at a rate of 0.125 mg/kg/h until the surgica
High dose Esketamine group (E2 group):After induction of anesthesia, a load dose of 0.25 mg/kg esketamine was administered, followed by continuous infusion at a rate of 0.25 mg/kg/h until the surgical
Blank control group (Group C):Give an equal amount of saline

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 89 Years

Inclusion criteria

Inclusion criteria: Elderly patients undergoing major abdominal surgery under general anesthesia, age=60 years old, ASAI-III, expect to stay in hospital for at least 3 days after surgery; Patients who signed informed consent forms.

Exclusion criteria

Exclusion criteria: ?BMI > 30kg/m2; ? known allergy to esketamine; ?Known to have hyperthyroidism or pheochromocytoma, grade III hypertension (very high risk), severe arrhythmia, severe cardiovascular and cerebrovascular disease or hemodynamic instability; ? severe hepatic and renal insufficiency; ? Recent use of any tricyclic antidepressants, sedatives, opioids, etc., within the past month; ? Refusal to provide informed consent or failure to cooperate;

Design outcomes

Primary

MeasureTime frame
Postoperative recovery quality QoR15;

Secondary

MeasureTime frame
Perioperative EEG characteristics of different doses of esketamine combined with propofol;VAS scores ;

Countries

China

Contacts

Public ContactChen Lijian

The First Affiliated Hospital of Anhui Medical University

chenlijian77@126.com+86 139 6669 9467

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026